The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center has been a pioneering force in biotechnology since its establishment in 1952. Positioned in the United States, the institute's groundbreaking research has had a tangible impact, touching various aspects of healthcare. The slogan, "Research with reach. (TM)", embodies the institute's commitment to impactful and far-reaching contributions. The institute's extensive portfolio of accomplishments underscores its significance in the medical field. From advancements in cholesterol testing to life-saving treatments for newborns and innovative surgical techniques, individuals around the world have directly benefited from the research conducted at The Lundquist Institute. This impact has been made possible via a unique collaboration with the esteemed Harbor-UCLA Medical Center, establishing a crucial bond between laboratory research, clinical application, and the wider community. In its latest milestone, the institute secured a substantial $3.80M grant investment from the National Heart, Lung and Blood Institute on 20 September 2023, signalling external validation and support for its ongoing research endeavors. This strong financial backing serves as a testament to the institute's continued relevance and potential for further impactful breakthroughs. In summary, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center stands as an influential force in the biotechnology landscape, with a rich history of achievements and a promising trajectory supported by substantial investment and strategic partnerships. Its dedication to pioneering research and real-world impact establishes a solid foundation for continued growth and significance in the ever-evolving healthcare sector.